Evaluation of Efficacy and Safety of Etanercept Therapy in Patients with Early and Late Juvenile Idiopathic Arthritis without Systemic Manifestations
Background: An issue related to the terms of assignment of genetically engineered biological agents to patients with juvenile idiopathic arthritis (JIA) still remains debatable in pediatric rheumatology.Objective: Our aim was to evaluate the efficacy and safety of etanercept therapy in early and lat...
Saved in:
Main Authors: | T. M. Bzarova (Author), E. I. Alexeeva (Author), S. I. Valieva (Author), R. V. Denisova (Author), K. B. Isaeva (Author), E. G. Chistyakova (Author), A. M. Chomakhidze (Author), T. V. Sleptsova (Author), A. N. Fetisova (Author), N. I. Taibulatov (Author) |
---|---|
Format: | Book |
Published: |
"Paediatrician" Publishers LLC,
2015-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LONG TERM FOLLOW-UP ON EFFECTIVENESS AND SAFETY OF ETANERCEPT IN JUVENILE IDIOPATHIC ARTHRITIS WITHOUT SYSTEMIC MANIFESTATIONS
by: A. A. Baranov, et al.
Published: (2015) -
ASSESSMENT OF THE QUALITY OF LIFE OF PATIENTS WITH THE JUVENILE IDIOPATHIC ARTHRITIS TREATED BY THE ETANERCEPT
by: A. N. Fetisova, et al.
Published: (2014) -
Evaluation of Efficacy and Safety of Etanercept and Etanercept + Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis without Systemic Manifestations
by: T. M. Bzarova, et al.
Published: (2016) -
Efficacy and Safety of Adalimumab Long-Term Administration with Immunosuppressants at Juvenile Idiopathic Arthritis without Systemic Manifestations
by: E. I. Alexeeva, et al.
Published: (2015) -
EFFICACY OF ETANERCEPT TREATMENT AS A SECOND TNF α INHIBITOR IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS AND PRIMARY AND SECONDARY INEFFICIENCY OR INTOLERANCE OF INFLIXIMAB
by: E. I. Alexeeva, et al.
Published: (2012)